IMCD N.V., a leading distributor, formulator, and solutions provider of speciality chemicals and ingredients headquartered in the Netherlands, has signed an agreement to acquire 100% of the shares of the speciality distribution company, Euro Chemo-Pharma Sdn Bhd and its wholly owned subsidiary, Biofresh Green Sdn Bhd.

Euro Chemo-Pharma was founded in Malaysia in 1975, offering a wide range of products, mainly food, pharmaceutical and personal care applications. Headquartered in Penang, with offices and warehouses also in Kuala Lumpur and Johor, it ensures the full coverage of the Malaysian market. The company also represents leading global suppliers providing its customers with an extensive portfolio backed by in-depth formulation expertise. With a generated revenue of approximately MYR 270 million in the financial year that ended on June 30, 2022, Euro Chemo-Pharma adds approximately 124 employees to the IMCD Malaysia team and an application laboratory in Penang.  

Additionally, Euro Chemo-Pharma’s subsidiary, Biofresh, includes blending, mixing, and compounding of food and flavour ingredients and holds the Halal certification.  

Photo caption- from left to right- Fenna van Zanten, M&A Director of IMCD Group; Jeryl Tan, Executive Director of Euro Chemo-Pharma; Teoh Seok Har, Director of Euro Chemo-Pharma; Tan Hooi Pheng, Founder and Managing Director of Euro Chemo-Pharma; Andreas Igerl, President of IMCD APAC; Vivien Tan, Executive Director of Euro Chemo-Pharma; Sylvia Tan, Shareholder of Euro Chemo-Pharma; and Emmanuel Colette, APAC Business Group Director of IMCD Food & Nutrition